We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

SPINREACT S.A.

SPINREACT develops and manufactures in vitro clinical diagnostic reagents in the areas of clinical chemistry, serolog... read more Featured Products: More products

Download Mobile App





Spinreact Presents Latest Developments in IVD

By LabMedica International staff writers
Posted on 07 Feb 2024
Print article
Image: The latest developments in IVD showcased at Medlab Middle East 2024 (Photo courtesy of Spinreact)
Image: The latest developments in IVD showcased at Medlab Middle East 2024 (Photo courtesy of Spinreact)

Spinreact (Girona, Spain) is presenting its latest developments in IVD at Medlab Middle East in Dubai, taking place February 5-8, 2024.

At Medlab Middle East 2024, Spinreact is showcasing the Spin XS fully automated clinical chemistry analyzer that allows labs to automate tests quickly and cost-effectively. The compact and economical instrument saves space, making it perfect for small and medium-sized laboratories. Spinreact is also highlighting the e-Spin10, an affordable, fast, and accurate electrolyte analyzer that can measure the concentration of up to 7 parameters: Na+, K+, Cl-, Ca2+, pH, Li+, TCO2 in whole blood, serum, plasma, and urine samples. It has a 7-inch touch screen, integrated printer, and optional automatic sample loader.

Among other products showcased at the event is the Spin 640 Plus clinical chemistry analyzer, which is a fully automated, high-volume tester perfectly suited to the needs of a large laboratory. The equipment has an automatic washing system with 8 stages, an internal barcode reader (optional), and coagulation detection of the samples. Spinreact is highlighting the Spincell 3n 3-part hematology analyzer that is designed to provide more confidence in the results and less response time to laboratories around the world. In addition to its compact size, it offers measurement of 22 parameters and three histograms, an HD touch screen, and a throughput of 72 samples per hour. The Spincell 3n is easy to use and economical and offers accurate results.

Visitors to the Spinreact booth at Medlab Middle East 2024 can also experience the Spinlab S semi-automatic chemical analyzer which features a large 7-inch color touch screen. Featuring a high-precision optical system with eight wavelengths, the Spinlab S offers both flowcell and disposable cuvette modes. Also featured at the show are the BIOBAS 10 single-channel coagulation analyzer with a micro-processor for programming parameters and making calculations, alongside the BIOBAS 20/40 coagulometers with two/four channels that are easy to use with programmable parameters and calculation of results.

Related Links:
Spinreact

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
New
PSA Test
Humasis PSA Card

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.